SEC Form 4 · accession 0001209191-17-065256
SANGAMO THERAPEUTICS, INC · SGMO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Curt A. Herberts III
Officer — Sr.VP & Chief Business Officer
Period of report
Dec 8, 2017
Accepted (ET)
Dec 12, 2017 · 6:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001001233
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 8, 2017 | F | 2,348 | $16.90 | D | 13,485 | D | |
| Common StockF1 | Dec 11, 2017 | F | 1,252 | $15.85 | D | 12,233 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares withheld to satisfy the Reporting Person's tax withholding obligation upon the vesting and issuance of shares of common stock underlying RSUs.